Intersect ENT, Inc. (XENT)

1 member of Congress has disclosed 2 trades in Intersect ENT, Inc. (XENT) via STOCK Act filings. The most recent disclosure was a purchase by Donna E. Shalala on 6 March 2019. Aggregate disclosed activity totals roughly $16K in purchases (midpoint estimates from bracketed disclosure amounts).

Want to automatically copy Pelosi trades?

Mirror Nancy Pelosi's portfolio with just one click on eToro.

Claim Free AssetCopy Automatically with eToro

Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.

Past Performance is not an indication of future results.

Price data is not available for XENT
This ticker may have been delisted, renamed, or is not publicly quoted, so no live price, statistics or chart can be shown. The congressional trades disclosed for it are listed below.

Congressional Trading Activity for XENT

2 transactions
Compliance: 50%
Donna E. Shalala6 Mar 201927 Apr 2020PurchaseStock$1,001 - $15,000N/A
Donna E. Shalala6 Mar 201921 Jul 2020PurchaseStock$1,001 - $15,000N/A

Stock Overview

Market Data

Market Cap

$0

Volume

0

Beta

1.53

P/E Ratio

-10.54

Fundamentals

EPS

$-2.68

Div. Yield

-

Open

$28.25

Day Range

$28.23 – $28.25

Company Information

Sector
Healthcare
Industry
Medical - Devices
Exchange
NASDAQ · USD
Country
US
CEO
Thomas West
IPO Date
2014-07-24
Website
www.intersectent.com

Intersect ENT, Inc. is a medical technology firm focused on ear, nose, and throat (ENT) solutions, operating within the United States. Its product portfolio includes: PROPEL, PROPEL Mini, and PROPEL Contour: These are steroid-eluting implants. PROPEL...

Earnings

Recent Quarters

Q1 20224 May
EPS$-0.85
Miss 150.0%
Q4 20218 Mar
EPS$-2.74
Q3 20212 Nov
EPS$-0.48
Miss 14.3%
Q2 20216 Aug
EPS$-0.49
Miss 11.4%
Q1 202110 May
EPS$-0.52
Miss 23.8%
Q4 20209 Mar
EPS$-0.62
Miss 93.8%
Q3 20202 Nov
EPS$-0.35
Beat 22.2%
Q2 20204 Aug
EPS$-0.71
Miss 26.8%
Q1 202011 May
EPS$-0.54
Miss 22.7%
Q4 201924 Feb
EPS$-0.25
Beat 28.6%
Q3 20191 Nov
EPS$-0.41
Miss 2.5%
Q2 20191 Aug
EPS$-0.36
Miss 5.9%
Q1 20196 May
EPS$-0.35
Miss 16.7%
Q4 201825 Feb
EPS$-0.16
Beat 0.0%
Q3 20185 Nov
EPS$-0.25
Beat 7.4%
Q2 20181 Aug
EPS$-0.14
Beat 12.5%
Q1 20181 May
EPS$-0.21
Beat 12.5%
Q4 201727 Feb
EPS$-0.11
Beat 38.9%
Q3 20172 Nov
EPS$-0.15
Beat 21.1%
Q2 20171 Aug
EPS$-0.08
Beat 57.9%
Q1 20172 May
EPS$-0.23
Beat 4.2%
Q4 201628 Feb
EPS$-0.17
Beat 10.5%
Q3 20162 Nov
EPS$-0.22
Beat 18.5%
Q2 20162 Aug
EPS$-0.21
Beat 19.2%
Q1 20165 May
EPS$-0.29
Beat 0.0%
Q4 201523 Feb
EPS$-0.20
Beat 20.0%
Q3 20154 Nov
EPS$-0.35
Miss 20.7%
Q2 20155 Aug
EPS$-0.23
Beat 11.5%
Q1 20156 May
EPS$-0.23
Beat 30.3%
Q4 201426 Feb
EPS$-0.16
Beat 44.8%
Q3 20145 Nov
EPS$-0.32
Beat 8.6%
Q1 201430 Jun
EPS$-0.19
Q4 201331 Mar
EPS$-0.25
Q3 201331 Dec
EPS$-0.27
Q2 201330 Sept
EPS$-0.23
Q1 201330 Jun
EPS$-0.28
Q4 201231 Mar
EPS$-0.27

No dividend data available for this stock.

No stock split data available for this stock.

Similar Stocks

Based on congressional trading patterns

Smart Recommendations
No similar stocks found
No congressional trading patterns available for recommendations

Frequently Asked Questions about XENT

Which members of Congress have traded XENT?
1 member of Congress has disclosed 2 trade in Intersect ENT, Inc. (XENT) under the STOCK Act: Donna E. Shalala.
When was XENT most recently disclosed by Congress?
The most recent XENT disclosure was a purchase by Donna E. Shalala on 6 March 2019.
What is the total disclosed congressional trading volume for XENT?
Members of Congress have disclosed approximately $16K in XENT purchases (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
How can I track new congressional trades in XENT?
This XENT page updates as soon as new STOCK Act disclosures are filed for Intersect ENT, Inc.. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Pelosi Tracker
PoliticiansBillsArticlesPortfoliosPricingAboutLegalTerms of ServicePrivacy Policy
Français
© 2026 - All rights reserved. Powered by Vantara Labs
Pelosi Tracker is an independent, third-party platform. It is not affiliated with, endorsed by, or in any way associated with Nancy Pelosi, her office or her representatives, or with any other member of Congress. Any use of her name is solely for the purpose of discussing publicly available information.The information provided by Pelosi Tracker is for informational and educational purposes only and is not intended to serve as, nor should it be construed as, financial or investment advice. The data presented here is sourced from publicly available filings and records. While we strive for accuracy, timeliness, and completeness, we do not guarantee that all information is error-free or current.